# K020558: Licox CC1.G2 Brain Oxygen Catheter-Microprobe

- Pathway: 510(k) (Special)
- Applicant: Integra Neurosciences
- Decided: Mar 21, 2002 after 29 days
- Product code: GWM (Device, Monitoring, Intracranial Pressure)
- Device class: 2
- Regulation: 21 CFR 882.1620
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K002765 (2000). 1 ancestor in all.
3 later devices descend from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K002765: Licox CMP Monitor-AC3.1, Licox Imc Oxygen Catheters-CC1,CC1.SB Luicox Imc Introducer Kits-IM,IM2,IM3,II1 Licoximc Tempe, Integra Neurosciences (2000) Summary page 1.

## Most influential descendants
- K040235: Licox Pmo Brain Monitoring System (2004), 2 descendants of its own
- K131184: Integra Licox PTO2 Monitor (2013), 0 descendants of its own
- K053244: Licox IT2 Complete Brain Tunneling Probe Kit (2006), 0 descendants of its own

## Indications for use
The LICOX® CC1.G2 is a brain oxygen catheter-microprobe intended for use with the LICOX Brain Oxygen Monitoring System. The LICOX Brain Oxygen Monitoring System measures intracranial oxygen and temperature and is intended as an adjunct monitor of trends of these parameters, indicating the perfusion status of cerebral tissue local to sensor placement. LICOX System values are relative within an individual, and should not be used as the sole basis for decisions as to diagnosis or therapy. It is intended to provide data additional to that obtained by current clinical practice in cases where hypoxia or ischemia are a concern.

Source page: https://510kreport.com/device/K020558
Methodology: https://510kreport.com/methodology